1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 11477443 | HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support. | 2001 Apr | 1 |